Differential humoral response against alpha- and beta-linked mannose residues associated with tissue invasion by Candida albicans
暂无分享,去创建一个
D. Poulain | T. Jouault | B. Sendid | C. Delaunoy | F. Ajana
[1] A. Casadevall,et al. Antibody immunity and invasive fungal infections , 1995, Infection and immunity.
[2] P. Trinel,et al. Mapping of beta-1,2-linked oligomannosidic epitopes among glycoconjugates of Candida species. , 1995, Microbiology.
[3] G. Santoni,et al. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection , 1995, Infection and immunity.
[4] Yongmoon Han,et al. Antibody response that protects against disseminated candidiasis , 1995, Infection and immunity.
[5] J. Wieruszeski,et al. Beta-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production , 1995, Infection and immunity.
[6] S. Kohno,et al. Plasma (1→3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes , 1995, The Lancet.
[7] S. Sternberg. The emerging fungal threat. , 1994, Science.
[8] P. Trinel,et al. The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages. , 1994, Immunology.
[9] T. Morgenthaler,et al. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components , 1994, Infection and immunity.
[10] T. Barbui,et al. Preventing Fungal Infection in Neutropenic Patients with Acute Leukemia: Fluconazole Compared with Oral Amphotericin B , 1994, Annals of Internal Medicine.
[11] E. Anaissie,et al. Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B , 1994, Cancer.
[12] W. Fibbe,et al. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] R. Sawyer,et al. Secretion of TNF‐α by alveolar macrophages in response to Candida albicans mannan , 1994, Journal of leukocyte biology.
[14] W. Hop,et al. Diagnostic value of anti-Candida enolase antibodies , 1994, Journal of clinical microbiology.
[15] E. F. Ullman,et al. An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species , 1994, Journal of clinical microbiology.
[16] S. Kohno,et al. Detection of candida enolase antibody in patients with candidiasis , 1994, Journal of clinical laboratory analysis.
[17] G. Nino,et al. Fungal polysaccharides. , 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[18] C. J. Morrison,et al. Nonculture methods for diagnosis of disseminated candidiasis , 1993, Clinical Microbiology Reviews.
[19] P. Trinel,et al. Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigen as a phospholipomannan containing beta-1,2-linked oligomannosides , 1993, Infection and immunity.
[20] R. Matthews,et al. Application of the polymerase chain reaction to the diagnosis of candidosis by amplification of an HSP 90 gene fragment. , 1993, Journal of medical microbiology.
[21] A. Iwama,et al. Improved survival from fungaemia in patients with haematological malignancies: Analysis of risk factors for death and usefulness of early antifungal therapy , 1993, European journal of haematology.
[22] J. Cutler,et al. Chemical definition of an epitope/adhesin molecule on Candida albicans. , 1993, The Journal of biological chemistry.
[23] C. Beck-Sague,et al. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.
[24] P. Trinel,et al. Qualitative and quantitative differences in recognition patterns of Candida albicans protein and polysaccharide antigens by human sera. , 1993, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[25] S. Suzuki,et al. Complete assignment of 1H and 13C nuclear magnetic resonance chemical shifts of beta-1,2-linked mannooligosaccharides isolated from the phosphomannan of the pathogenic yeast Candida albicans NIH B-792 strain. , 1993, Archives of biochemistry and biophysics.
[26] P. Jacquinot,et al. Probable presence of beta(1-2)-linked oligomannosides that act as human immunoglobulin G3 epitopes and are distributed over a Candida albicans 14- to 18-kilodalton antigen , 1993, Infection and immunity.
[27] M. Arai,et al. Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B-792 (serotype B) and J-1012 (serotype A) as beta-1,2-linked oligomannosyl residues , 1992, Infection and immunity.
[28] P. Jacquinot,et al. Mapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies , 1992, Infection and immunity.
[29] J. Graybill,et al. Fungal infections in AIDS patients. , 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[30] J. Wieruszeski,et al. 1H-NMR spectroscopy of manno-oligosaccharides of the beta-1,2-linked series released from the phosphopeptidomannan of Candida albicans VW-32 (serotype A). , 1991, Biochemical and biophysical research communications.
[31] A. Nakamura,et al. Diagnosis of invasive candidiasis by detection of mannan antigen by using the avidin-biotin enzyme immunoassay , 1991, Journal of clinical microbiology.
[32] J. Burnie,et al. The application of epitope mapping in the development of a new serological test for systemic candidosis. , 1991, Journal of immunological methods.
[33] E. Kurstak. Immunology of fungal diseases , 1991 .
[34] J. Edwards. Invasive candida infections--evolution of a fungal pathogen. , 1991, The New England journal of medicine.
[35] A. MacGowan,et al. Prophylactic oral fluconazole and candida fungaemia , 1991, The Lancet.
[36] R. Nelson,et al. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action , 1991, Clinical Microbiology Reviews.
[37] S. Suzuki,et al. Immunochemistry of Candida Mannans , 1991 .
[38] J. Latgé,et al. Fungal Cell Wall and Immune Response , 1991, NATO ASI Series.
[39] G. Strecker,et al. Immunoreactivity of neoglycolipids constructed from oligomannosidic residues of the Candida albicans cell wall , 1990, Infection and immunity.
[40] J. Dupouy-Camet,et al. Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis , 1990, Journal of clinical microbiology.
[41] E. Evans,et al. Serological tests in the diagnosis and prognosis of fungal infection in the compromised patient. , 1990 .
[42] R. Woolson,et al. Risk factors for hospital-acquired candidemia. A matched case-control study. , 1989, Archives of internal medicine.
[43] J. Domer. Candida cell wall mannan: a polysaccharide with diverse immunologic properties. , 1989, Critical reviews in microbiology.
[44] Y. Fukazawa. Antigenic structure of Candida albicans. Immunochemical basis of the serologic specificity of the mannans in yeasts. , 1989, Immunology series.
[45] J. Burnie,et al. Diagnosis of systemic candidiasis by an enzyme-linked dot immunobinding assay for a circulating immunodominant 47-kilodalton antigen , 1988, Journal of clinical microbiology.
[46] T. Mikami,et al. Preparation of monoclonal antibodies reactive with beta-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain. , 1988, Clinical chemistry.
[47] G. Soe,et al. Production and characterization of agglutinating monoclonal antibodies against predominant antigenic factors for Candida albicans. , 1986, Journal of clinical microbiology.
[48] J. Burnie,et al. IMMUNOBLOT ANALYSIS OF THE SEROLOGICAL RESPONSE IN SYSTEMIC CANDIDOSIS , 1984, The Lancet.
[49] D. Warnock,et al. Fungal infection in the compromised patient. , 1982 .
[50] Richardson,et al. Serological Tests in the Diagnosis and Prognosis of Fungal Infection in the Compromised Patient , 1982 .
[51] F. Odds,et al. Distribution of pathogenic yeasts and humoral antibodies to candida among hospital inpatients. , 1980, Journal of clinical pathology.
[52] W. Chew,et al. Candida precipitins. , 1967, Journal of immunology.